Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Eagle Pharmaceuticals (NQ: EGRX ) 5.600 +0.580 (+11.55%) Streaming Delayed Price Updated: 4:00 PM EDT, Jun 28, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 2,111,321 Open 5.030 Bid (Size) 5.510 (3) Ask (Size) 5.650 (11) Prev. Close 5.020 Today's Range 4.950 - 5.600 52wk Range 3.210 - 23.52 Shares Outstanding 12,698,566 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News 12 Health Care Stocks Moving In Wednesday's Intraday Session May 22, 2024 Via Benzinga The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Eagle Pharmaceuticals, Inc. (EGRX) February 08, 2024 From The Law Offices of Frank R. Cruz Via Business Wire Performance YTD -1.06% -1.06% 1 Month +63.50% +63.50% 3 Month +17.40% +17.40% 6 Month -1.06% -1.06% 1 Year -71.19% -71.19% More News Read More EAGLE PHARMACEUTICALS 48 HOUR DEADLINE ALERT: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Eagle Pharmaceuticals To Contact Him Directly To Discuss Their Options February 08, 2024 From Faruqi & Faruqi LLP Via GlobeNewswire ROSEN, LEADING INVESTOR COUNSEL, Encourages Eagle Pharmaceuticals, Inc. Investors to Secure Counsel Before Important February 9 Deadline in Securities Class Action - EGRX February 06, 2024 Via NewMediaWire Topics Lawsuit Exposures Financial Legal ROSEN, LEADING INVESTOR COUNSEL, Encourages Eagle Pharmaceuticals, Inc. Investors to Secure Counsel Before Important February 9 Deadline in Securities Class Action - EGRX February 06, 2024 Via TheNewswire.com Topics Lawsuit Exposures Financial Legal Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Eagle Pharmaceuticals, Golden Heaven, Inspire Medical, and Driven and Encourages Investors to Contact the Firm February 04, 2024 From Bragar Eagel & Squire Via GlobeNewswire ROSEN, NATIONAL TRIAL COUNSEL, Encourages Eagle Pharmaceuticals, Inc. Investors to Secure Counsel Before Important February 9 Deadline in Securities Class Action – EGRX February 04, 2024 From The Rosen Law Firm PA Via GlobeNewswire ROSEN, LEADING INVESTOR COUNSEL, Encourages Eagle Pharmaceuticals, Inc. Investors to Secure Counsel Before Important February 9 Deadline in Securities Class Action - EGRX February 02, 2024 Via NewMediaWire Topics Lawsuit Exposures Financial Legal ROSEN, LEADING INVESTOR COUNSEL, Encourages Eagle Pharmaceuticals, Inc. Investors to Secure Counsel Before Important February 9 Deadline in Securities Class Action - EGRX February 02, 2024 Via TheNewswire.com Topics Lawsuit Exposures Financial Legal ROSEN, A LEADING LAW FIRM, Encourages Eagle Pharmaceuticals, Inc. Investors to Secure Counsel Before Important February 9 Deadline in Securities Class Action – EGRX February 01, 2024 From The Rosen Law Firm PA Via GlobeNewswire EAGLE PHARMACEUTICALS INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Eagle Pharmaceuticals To Contact Him Directly To Discuss Their Options February 01, 2024 From Faruqi & Faruqi LLP Via GlobeNewswire Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Microvast, Eagle Pharmaceuticals, Golden Heaven, and Inspire Medical and Encourages Investors to Contact the Firm January 31, 2024 From Bragar Eagel & Squire Via GlobeNewswire ROSEN, LEADING INVESTOR COUNSEL, Encourages Eagle Pharmaceuticals, Inc. Investors to Secure Counsel Before Important February 9 Deadline in Securities Class Action - EGRX January 29, 2024 Via NewMediaWire Topics Lawsuit Exposures Financial Legal ROSEN, LEADING INVESTOR COUNSEL, Encourages Eagle Pharmaceuticals, Inc. Investors to Secure Counsel Before Important February 9 Deadline in Securities Class Action - EGRX January 29, 2024 Via TheNewswire.com Topics Lawsuit Exposures Financial Legal ROSEN, A TOP RANKED LAW FIRM, Encourages Eagle Pharmaceuticals, Inc. Investors with Losses to Secure Counsel Before Important February 9 Deadline in Securities Class Action - EGRX January 28, 2024 Via NewMediaWire Topics Lawsuit Exposures Financial Legal ROSEN, A TOP RANKED LAW FIRM, Encourages Eagle Pharmaceuticals, Inc. Investors with Losses to Secure Counsel Before Important February 9 Deadline in Securities Class Action - EGRX January 28, 2024 Via TheNewswire.com Topics Lawsuit Exposures Financial Legal Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Microvast, Eagle Pharmaceuticals, Golden Heaven, and Inspire Medical and Encourages Investors to Contact the Firm January 27, 2024 From Bragar Eagel & Squire Via GlobeNewswire EAGLE PHARMACEUTICALS SHAREHOLDER NOTICE: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Eagle Pharmaceuticals To Contact Him Directly To Discuss Their Options January 24, 2024 From Faruqi & Faruqi LLP Via GlobeNewswire Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Fisker, Microvast, Eagle Pharmaceuticals, and Golden Heaven and Encourages Investors to Contact the Firm January 23, 2024 From Bragar Eagel & Squire Via GlobeNewswire ROSEN, SKILLED INVESTOR COUNSEL, Encourages Eagle Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - EGRX January 23, 2024 Via NewMediaWire Topics Lawsuit Exposures Financial Legal ROSEN, SKILLED INVESTOR COUNSEL, Encourages Eagle Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - EGRX January 23, 2024 Via TheNewswire.com Topics Lawsuit Exposures Financial Legal ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Eagle Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – EGRX January 22, 2024 From The Rosen Law Firm PA Via GlobeNewswire NATIONALLY RANKED ROSEN LAW FIRM Encourages Eagle Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - EGRX January 21, 2024 Via NewMediaWire Topics Lawsuit Exposures Financial Legal Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Fisker, Microvast, Eagle Pharmaceuticals, and Golden Heaven and Encourages Investors to Contact the Firm January 19, 2024 From Bragar Eagel & Squire Via GlobeNewswire ROSEN, A LEADING NATIONAL FIRM, Encourages Eagle Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - EGRX January 19, 2024 Via NewMediaWire Topics Lawsuit Exposures Financial Legal Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.